Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

J&j
Topics

Advertisement

J&j

Showing articles that match j&j in the headline

Yesterday

SpaceX IPO Mints Windfalls as Intellia Trial Cuts Attacks 87%, J&J Risk Falls 53% Coinotag 20:52 Sun, 14 Jun

Saturday

J&J Trial Over Doctor's Cancer Death Ends In Settlement Law360 01:29 Sat, 13 Jun

Friday

J&J poster puts Spravato remission data at center of treatment-resistant-depression growth push Drug Discovery & Development 22:55 Fri, 12 Jun

Advertisement

Advertisement

J&J Moves to Shed Cases Claiming Talc Products Caused Cancer Bloomberg Law 21:35 Fri, 12 Jun

J&J reports data from Phase II/III ENERGY trial for wAIHA Clinical Trials Arena 16:04 Fri, 12 Jun

Analiză Forbes: Tranzacțiile GSK, J&J și Polpharma declanșează noul ciclu global al industriei farma și life sciences real estate Forbes.ro 11:54 Fri, 12 Jun

Thursday

J&J’s Imaavy Goes Two-For-Two With Pivotal Trial Success In wAIHA Scrip Pharma Intelligence 21:58 Thu, 11 Jun

J&J Snack Foods Top Lawyer Resigns as Legal Chief Exits Keep Piling Up Law.com 21:08 Thu, 11 Jun

J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win FiercePharma 17:27 Thu, 11 Jun

J&J Expands U.S. Availability Of Tecnis PureSee Iol For Cataract Patients RTT News 14:36 Thu, 11 Jun

J&J adds rare disease wAIHA to Imaavy's potential uses pharmaphorum 14:05 Thu, 11 Jun

Wednesday

J&J Hit With $32M Verdict In LA Baby Powder Cancer Trial Law360 22:53 Wed, 10 Jun

J&J Opts Not To Follow The Oncology Crowd Scrip Pharma Intelligence 22:32 Wed, 10 Jun

AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings FiercePharma 07:30 Wed, 10 Jun

Advertisement

Tuesday

J&J to Expand Cancer Pipeline With $1B Firefly Bio Acquisition Zacks 17:29 Tue, 09 Jun

J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline Pharmaceutical Business Review 11:23 Tue, 09 Jun

J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology 09:48 Tue, 09 Jun

In the last month

J&J Moves Into Two Hot Cancer Drug Areas At Once With $1bn Firefly Buy Scrip Pharma Intelligence 23:31 Mon, 08 Jun

Incyte nabs potential Vwd game-changer in Vega deal; J&J buys Firefly BioWorld 21:59 Mon, 08 Jun

J&J lights up $1bn offer for pan-KRAS developer Firefly pharmaphorum 14:49 Mon, 08 Jun

STAT Plus: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more STAT 14:38 Mon, 08 Jun

STAT Plus: J&J spends $1 billion to enter KRAS race for cancer treatments STAT 14:27 Mon, 08 Jun

J&J to buy cancer drug technology developer Firefly Bio for $1 billion Rock Hill Herald 13:39 Mon, 08 Jun

BREAKING: J&J Cleared Of Talc Liability In LA Bellwether Trial Law360 00:30 Sat, 06 Jun

J&J beats lawsuit alleging that talc caused three women's cancer The News Tribune, Washington 23:34 Fri, 05 Jun

No 'Conspiracy To Hide Asbestos' In Talc, J&J Atty Tells Jury Law360 03:07 Fri, 05 Jun

J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study Hospital Management 10:17 Thu, 04 Jun

J&J Innovative Medicine Korea wins reimbursement for Darzalex SC regimen in newly diagnosed AL amyloidosis Korea Biomedical Review 06:09 Thu, 04 Jun

'This Is Their Document': Jury Told J&J Docs Prove Talc Lies Law360 02:30 Thu, 04 Jun

Good News For FcRn Class With J&J’s Imaavy Data In Lupus Scrip Pharma Intelligence 19:46 Wed, 03 Jun

Paul Hastings Settles With J&J Unit in Bankruptcy Fee Dispute Bloomberg Law 19:38 Wed, 03 Jun

Talc Tester Says J&J Never Pressured Him To Hide Asbestos Law360 02:36 Wed, 03 Jun

J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis PMLiVE 12:59 Tue, 02 Jun

Ga. Panel Says New Trial Warranted In J&J Talc Cancer Suit Law360 01:47 Tue, 02 Jun

J&J’s Erleada Shows Survival Benefit Versus Standard Of Care With Surgery Scrip Pharma Intelligence 22:07 Mon, 01 Jun

J&J Drug Reduces Prostate Cancer Progression NewsMax 13:41 Mon, 01 Jun

J&J Asset Management pushes for board overhaul at Daeho AL HedgeWeek 13:35 Mon, 01 Jun

ASCO26: BMS and J&J debut shining multiple myeloma data Clinical Trials Arena 12:11 Mon, 01 Jun

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study The Tribune, California 13:29 Sun, 31 May

ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win FiercePharma 13:08 Sun, 31 May

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Climate Crisis
UK UK
World World
Business Business
Entertainment
Sport Sport
Football Football
Technology Technology
Science Science
Lifestyle Lifestyle
Industry Sectors